ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 133 filers reported holding ARRAY BIOPHARMA INC in Q3 2013. The put-call ratio across all filers is 16.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $21,788,000 | +513.2% | 470,283 | +120.9% | 0.47% | +589.7% |
| Q2 2018 | $3,553,000 | +10.7% | 212,898 | +8.2% | 0.07% | 0.0% |
| Q1 2018 | $3,211,000 | +1154.3% | 196,754 | +849.1% | 0.07% | +1260.0% |
| Q3 2017 | $256,000 | -79.2% | 20,731 | -85.9% | 0.01% | -80.0% |
| Q2 2017 | $1,231,000 | -32.4% | 147,110 | -27.8% | 0.02% | -43.2% |
| Q1 2017 | $1,820,000 | -59.2% | 203,630 | -80.9% | 0.04% | -58.1% |
| Q4 2015 | $4,459,000 | +3178.7% | 1,064,085 | +3252.2% | 0.10% | +2525.0% |
| Q2 2014 | $136,000 | -47.9% | 31,743 | -39.1% | 0.00% | -42.9% |
| Q4 2013 | $261,000 | -86.2% | 52,163 | -82.8% | 0.01% | -83.3% |
| Q3 2013 | $1,885,000 | -22.6% | 303,118 | -43.5% | 0.04% | -36.4% |
| Q2 2013 | $2,436,000 | – | 536,646 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |